Alpha Score of 50 reflects weak overall profile with weak momentum, moderate value, weak quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
| Politician | Date | Type | Amount |
|---|---|---|---|
| Valerie Hoyle D-OR | 2025-09-23 | sale | $1k – $15k |
| Lisa McClain R-MI | 2025-06-24 | purchase | $1k – $15k |
| Valerie Hoyle D-OR | 2024-10-29 | purchase | $1k – $15k |
| Josh Gottheimer D-NJ | 2024-05-20 | purchase | $1k – $15k |
| Josh Gottheimer D-NJ | 2023-07-19 | purchase | $1k – $15k |
| Daniel Goldman NY | 2023-02-27 | purchase | $1k – $15k |
Haleon Plc - ADR represents an American Depositary Receipt for Haleon Plc, a company known for its focus on consumer healthcare products. ADRs are traded on U.S. stock exchanges and allow American investors to invest in non-U.S. companies without dealing with foreign transactions. Haleon Plc specializes in providing health-related products across various categories, including oral health, pain relief, vitamins, minerals, and supplements, as well as digestive health and other wellness products. The company is a significant player in the global consumer healthcare market, serving regions worldwide. By offering solutions that cater directly to consumer health needs, Haleon's products find utilization in countless households, impacting consumer health and wellness sectors globally. As a spin-off from GlaxoSmithKline (GSK), Haleon continues its legacy of developing solutions aimed at improving everyday health, holding an important role within the healthcare industry due to its broad range of trusted brands and deep industry expertise.
Earnings calendar coming soon. Subscribe to get notified when HLN reports next.
Get earnings alerts →